Hypothalamic lesions in multiple sclerosis

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 82, Issue 7, 2011, Pages 819-822

  Qiu, Wei ^a,b,c   Raven, Sonja ^d   Wu, Jing Shan ^a,b   Bundell, Christine ^e   Hollingsworth, Peter ^e   Carroll, William M ^a,b   Mastaglia, Frank L ^a,b   Kermode, Allan G ^a,b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^c SUN YAT SEN UNIVERSITY   (China)

^d Neurointerventional and Imaging Services of Western Australia   (Australia)

^e PATHWEST LABORATORY MEDICINE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY;

ADULT; AGED; ARTICLE; BRAIN DAMAGE; CAUCASIAN; CONTROLLED STUDY; FEMALE; HUMAN; HYPOTHALAMUS DISEASE; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; MYELOOPTIC NEUROPATHY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SPINAL CORD DISEASE;

EID: 79959873391     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2009.198192     Document Type: Article

References (26)

1. Huitinga I, De Groot CJ, Van der Valk P, et al. Hypothalamic lesions in multiple sclerosis. J Neuropathol Exp Neurol 2001;60:1208-18. (Pubitemid 33117101)
2. Kamalian N, Keesey RE, ZuRhein GM. Lateral hypothalamic demyelination and cachexia in a case of 'malignant' multiple sclerosis. Neurology 1975;25:25-30.
3. Kira J, Harada M, Yamaguchi Y, et al. Hyperprolactinemia in multiple sclerosis. J Neurol Sci 1991;102:61-6.
4. Weiss N, Hasboun D, Demeret S, et al. Paroxysmal hypothermia as a clinical feature of multiple sclerosis. Neurology 2009;72:193-5.
5. Zellini F, Niepel G, Tench CR, et al. Hypothalamic involvement assessed by T1 relaxation time in patients with relapsing-remitting multiple sclerosis. Mult Scler 2009;15:1442-9.
6. Pittock SJ, Lennon VA, Krecke K, et al. Brain abnormalities in neuromyelitis optica. Arch Neurol 2006;63:390-6.
7. Poppe AY, Lapierre Y, Melancon D, et al. Neuromyelitis optica with hypothalamic involvement. Mult Scler 2005;11:617-21. (Pubitemid 41387709)
8. Viegas S, Weir A, Esiri M, et al. Symptomatic, radiological and pathological involvement of the hypothalamus in neuromyelitis optica. J Neurol Neurosurg Psychiatry 2009;80:679-82.
9. EMEA. Home page, section 5.1, Tysabri product information: Annex I: Summary of product characteristics. http://www.emea.europa.eu/humandocs/PDFs/ EPAR/tysabri/emea-combined-h603en.pdf (accessed 1 Oct 2009).
10. McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001;50:121-7.
11. Wei Q, Wu JS, Zhang MN, et al. Longitudinally extensive myelopathy in Caucasians: a West Australian study of 26 cases from the Perth Demyelinating Diseases Database. J Neurol Neurosurg Psychiatry 2010;81:209-12.
12. Wingerchuk DM, Hogancamp WF, O'Brien PC, et al. The clinical course of neuromyelitis optica (Devic's syndrome). Neurology 1999;53:1107-14. (Pubitemid 29442132)
13. Saleem SN, Said AH, Lee DH. Lesions of the hypothalamus: MR imaging diagnostic features. Radiographics 2007;27:1087-108.
14. Lennon VA, Wingerchuk DM, Kryzer TJ, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 2004;364:2106-12. (Pubitemid 39626806)
15. Wei Q, Christine B, Jing-Shan W, et al. Low level of systemic autoimmunity in Western Australian multiple sclerosis patients. Mult Scler 2010;16:351-4.
16. Matsuoka T, Matsushita T, Kawano Y, et al. Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese. Brain 2007;130:1206-23. (Pubitemid 47355945)
17. Waters P, Vincent A. Detection of anti-aquaporin-4 antibodies in neuromyelitis optica: current status of the assays. Int MS J 2008;15:99-105.
18. Fazio R, Malosio ML, Lampasona V, et al. Antiacquaporin 4 antibodies detection by different techniques in neuromyelitis optica patients. Mult Scler 2009;15:1153-63.
19. Nakashima I, Fujihara K, Miyazawa I, et al. Clinical and MRI features of Japanese patients with multiple sclerosis positive for NMO-IgG. J Neurol Neurosurg Psychiatry 2006;77:1073-5. (Pubitemid 44338534)
20. Cabrera-Gomez JA, Quevedo-Sotolongo L, Gonzalez-Quevedo A, et al. Brain magnetic resonance imaging findings in relapsing neuromyelitis optica. Mult Scler 2007;13:186-92. (Pubitemid 46592770)
21. Matsushita T, Matsuoka T, Ishizu T, et al. Anterior periventricular linear lesions in optic-spinal multiple sclerosis: a combined neuroimaging and neuropathological study. Mult Scler 2008;14:343-53. (Pubitemid 351676429)
22. Triulzi F, Scotti G. Differential diagnosis of multiple sclerosis: contribution of magnetic resonance techniques. J Neurol Neurosurg Psychiatry 1998;64(Suppl 1):S6-14.
23. Calabrese M, Gallo P. Magnetic resonance evidence of cortical onset of multiple sclerosis. Mult Scler 2009;15:933-41.
24. Jarius S, Paul F, Franciotta D, et al. Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica. Nat Clin Pract Neurol 2008;4:202-14. (Pubitemid 351516748)
25. Bichuetti DB, Oliveira EM, Souza NA, et al. Neuromyelitis optica in Brazil: a study on clinical and prognostic factors. Mult Scler 2009;15:613-19.
26. Kermode AG. Aquaporin-4 IgG: overview and future perspectives. Neurology Asia 2008;13:179-83.